Navigation Links
Hemophilia Drug Used Off-Label Raises Clot Risk
Date:11/4/2010

p>rFVIIa was approved about 10 years ago by the U.S. Food and Drug Administration for use in people with hemophilia. Hemophilia is a group of blood disorders in which the blood doesn't clot properly, raising the risk of prolonged bleeding, internal bleeding and bleeding into the joints.

Increasingly, the drug has also been used for so-called "off-label" use, or to treat conditions not expressly licensed by the FDA, Aledort said. While it is legal for physicians to use a drug in this way, a drug's maker cannot promote its use for anything but the condition for which it is approved.

Such "off-label" uses include stopping brain bleeds and staunching bleeding during surgery due to trauma or advanced liver disease, according to the study.

Despite it's effectiveness in stopping bleeding and promoting beneficial clotting, there have been reports of complications, including heart attacks and stroke.

In the study, researchers looked at 35 published and unpublished studies on off-label usage of rFVIIa to treat or prevent bleeding. The studies involved more than 4,100 people who experienced excessive bleeding, some of whom were given rFVIIa and some who weren't. Overall, about 11 percent experienced arterial thrombosis, most often a heart attack, unstable angina (a precursor to a heart attack) or stroke.

About 5.5 percent of those who received rFVIIa experienced arterial thrombosis, compared to 3.2 percent of those who were given a placebo.

About 2.9 percent of those who received rFVIIa had a heart attack compared to about 1.1 percent given a placebo.

The risk of dangerous clots rose with age. Among those 65 and older, 9 percent of those given rFVIIa experienced arterial thrombosis compared to 3.8 percent given a placebo. For those 75 and up, rates rose to 10.8 percent and 4.1 percent, respectively.

There was no increased risk of venous thrombosis, such as clots in the legs or lungs (pulmonary embolism).

"The company
'/>"/>

Copyright©2010 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Pfizer Hemophilia presents new data at the World Federation of Hemophilia 2010 Congress
2. Study raises concern about ability of tests to predict fertility
3. Web Connection Raises Chances of Romance
4. Spread of Whooping Cough Raises Concern
5. Avandia Raises Heart Risk But Should Stay on Market, FDA Panel Finds
6. Hormone Raises Desire for Fattening Foods
7. Pro Ana Versus Pro Recovery Sites: New Study by Johns Hopkins and Stanford University raises concerns.
8. Apptera Raises $10M to Grow Its Voice And Visual Mobile Ad Network
9. Department of Labor Raises the Bar
10. AFOP's Children in the Fields Campaign Raises Awareness of Child Labor in the U.S.
11. Low IQ Among Males Raises Suicide Risk
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hemophilia Drug Used Off-Label Raises Clot Risk
(Date:1/22/2015)... The federal court overseeing thousands of vaginal ... Southern District of West Virginia has upheld a $2 million ... bellwether trial. In an Order dated January 21st, the Court ... that C.R. Bard had not proven a miscarriage of justice. ...
(Date:1/22/2015)... 20 years, Dr. David Cruz of Cruz Chiropractic Care ... about every type of injury that can result from car accidents ... years, the team at Doctors on Liens has been ... With the combined breadth of experience between the two, ...
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy ... its highest annual revenues in the past three years. Today, ... wedding dresses. , According to the sales manager of the ... for them in 2015. This point can be reflected on ...
(Date:1/22/2015)... New York, NY (PRWEB) January 22, 2015 ... component of overall health care gains momentum worldwide, Rev. ... York-based HealthCare Chaplaincy Network (HCCN), will be the ... advance spiritual care in Israel’s public health system. , The ...
(Date:1/22/2015)... Ga., USA (PRWEB) January 22, 2015 ... a statewide data management system with support from GEOSYSTEMS, ... , The new solution will leverage Hexagon Geospatial’s ... and vector data as well as point clouds and ...
Breaking Medicine News(10 mins):Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 2Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 3Health News:Court Upholds $2 Million Vaginal Mesh Lawsuit Verdict Levied Against C.R. Bard in First Federal Bellwether Trial, Bernstein Liebhard LLP Reports 4Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 2Health News:HealthCare Chaplaincy CEO to Keynote Spiritual Care Summit in Israel 3Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 2Health News:State Forestry Institute Mecklenburg-Vorpommern, Germany Embraces Hexagon Geospatial Technology 3
... , , SAN ... Cetyl Max/Flexadren mischaracterized certain facts associated with the ... Board: IAGX). Both companies extend their apologies to ... affected by the mischaracterization. , , ...
... , , MINNEAPOLIS, Aug. 13 ... will be the new Director of Research for the organization. Dr. ... of Oregon and the University of Minnesota. , , ... Minnesota and our research department," said David Willoughby, Chief Executive Officer ...
... activity reduces depression and fatigue , THURSDAY, Aug. 13 ... and depression experienced by leukemia patients who are undergoing ... people who did individualized exercise sessions while in the ... induction phase of leukemia treatment. The sessions included aerobic ...
... so high , , THURSDAY, Aug. 13 (HealthDay News) -- ... and policymakers would like, two U.S. health agencies have decided ... Centers for Disease Control and Prevention and the Office of ... and Human Services, are spending much of Thursday at CDC ...
... , SAN JOSE, Calif., Aug. 13 Human Pheromone Sciences, ... for the three and six months ended June 30, 2009. For the ... a 5% decrease from the revenues of $236,000 in the prior year ... as compared with a net loss of $88,000 ($0.02 per share) for ...
... ... health care plan currently under consideration in Congress. After pouring through the entire document, he ... is no coverage for illegal aliens, and the parental education is largely voluntary, and driven ... financial side. , ...
Cached Medicine News:Health News:Exercise May Help in Leukemia Recovery 2Health News:It's Time for More Moms to Breast-Feed, U.S. Officials Say 2Health News:It's Time for More Moms to Breast-Feed, U.S. Officials Say 3Health News:Human Pheromone Sciences Announces Second Quarter Results 2Health News:Human Pheromone Sciences Announces Second Quarter Results 3Health News:Human Pheromone Sciences Announces Second Quarter Results 4Health News:Analysis of the Proposed Health Care Legislation Finds Financial Aspects May be Difficult to Forecast 2
(Date:1/23/2015)... 2015  HyGreen, Inc., a leader in hand hygiene monitoring, ... Medical, a subsidiary of Ascendis Health Limited, in ... year, hundreds of millions of patients around the world ... transmitted from patient to patient via the unwashed hands ...
(Date:1/23/2015)... Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC Bulletin Board: ... Preliminary Proxy Statement, Schedule 14A, with the U.S. Securities & ... for shareholders detailing why a "YES" vote to increase the ... As we reflect upon the 2014 fiscal year ...
(Date:1/23/2015)... , Jan. 23, 2015 Gem Pharmaceuticals announced ... have been enrolled into the Company,s Phase 2 clinical ... safety of Gem,s lead compound, GPX-150 (an investigational medication), ... or metastatic disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:HyGreen Partners with RCA Medical in Johannesburg, South Africa 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... AUSTIN, Texas, June 29, 2011 Ascension Orthopedics, Inc., the ... the PyroTITAN™ Humeral Resurfacing Implant in Geelong, Australia by Richard ... "The patient was a 57-year-old, active male with ... by a fall from a mountain bike and not improved ...
... 2011 Medicines can cure disease, relieve symptoms, and ... a lot of damage if taken incorrectly, when not ... http://photos.prnewswire.com/prnh/20090824/FDALOGO ) Studies estimate that up ... be prevented. Learn how FDA—through its Safe ...
Cached Medicine Technology:Ascension Orthopedics Implants PyroTITAN™ in Geelong, Australia 2
... the only four-color, automated benchtop flow cytometry ... cell sorting. Designed specifically to support a ... offers software instrument control, auto-sample loading, and ... productivity. FACSCalibur is fully modular so it ...
... mobile flow cytometer for any kind ... counting. The CyFlow SL analyzes forward ... with up to 3 fluorescence channels. ... is performed with a PC or ...
The Elecsys 2010 Rack System streamlines processes and allows for smooth implementation of laboratory automation....
... an automated, multiparametric immunoassay system. ... stores the calibration in the ... cost-per-patient result. Plus, with its ... of use and uni/bi-directional interface, ...
Medicine Products: